Emergent Biosolutions Inc. · NYSE:EBS
BlackRock, Inc. reported a 9.00% stake in Emergent Biosolutions Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 28, 2026
BlackRock, Inc. reported a 9.00% stake in Emergent Biosolutions Inc., 4,651,339 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).
- Stake
- 9.00%
- Shares
- 4,651,339
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 9.00% | 4,651,339 |
Source
Related
- Emergent Biosolutions Inc.
- BlackRock, Inc.
- Emergent Biosolutions Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Form 4 · DeGolyer Donald W · Oct 7, 2026
- Form 4 · Williams Paul Anthony · Oct 5, 2026
- Schedule 13G · American Century Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Williams Paul Anthony · Jul 2, 2026